RankAlpha logo
Back to Rankings

MLTX

MoonLake ImmunotherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
MLTX vs peer average
24/100
MLTX vs. peer average (D vs. B)
Grade spread
A 1 · B 2 · C 1 · D 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

URGN is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.29B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerURGNUroGen
MLTX
MoonLake Immunotherapeutics
URGN
UroGen
Grade
D
B
Momentum
55
92
Value
41
41
Sentiment
-
44
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs URGN

MLTX / URGN
Grade Position
Below peers
MLTX vs. peer average (D vs. B)
24/100
Momentum
55
URGN
Value
41
MLTX
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MLTX
1
URGN
UroGen Pharma Ltd Common
B
80/100
-2
2
BCAX
Bicara Therapeutics Inc Common
N/A
-
-
3
BLFS
BioLife Solutions Inc Common
A
100/100
-3
4
MAZE
Maze Therapeutics Inc Common
N/A
-
-
5
IMTX
Immatics NV Common
B
80/100
-2
URGN is the first peer returned for this comparison set.